Thursday May 25th 2017

Archive for October, 2012

Canadian study tracks MS patients after ‘liberation treatment’

Canadian study tracks MS patients after ‘liberation treatment’

A Canadian study that tracked 80 multiple sclerosis patients who underwent the controversial “liberation treatment” outside of the country suggests that about half of them saw their symptoms improve after the procedure. Researchers in British Columbia surveyed 80 people [Read More]

MS patients don’t have years to wait for studies

MS patients don’t have years to wait for studies

Like all of those suffering from MS, or with a loved one with MS, I have been following the latest news with interest. Once again, the bait of possible liberation treatment availability in this province/country is dangled in front of our noses, and once again my phone is [Read More]

Finally, CCSVI clinical trials. So why is everyone so pissed off?

Finally, CCSVI clinical trials. So why is everyone so pissed off?

On Friday, the Canadian government announced approval of clinical trials into the safety and efficacy of treatment for cerebrospinal venous insufficiency, better known as CCSVI. Health Minister Leona Aglukkaq broke the news at a health ministers’ meeting more than five [Read More]

Latest Topics

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care [Read More]

Roche investigating case of patient illness after taking MS drug

Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche ’s new multiple sclerosis drug Ocrevus has been diagnosed [Read More]

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]